CEO Communique

The Medlab Story

Tuesday 2ND April 2019


CEO Communique

First, let me start by saying the recent APP conference on the Gold Coast was amazing, “a big thank you to the conference coordinators!”

As some of you may already know, APP, is the largest pharmacy conference in Australia and was the launch vehicle for Medlab’s self-branded nutraceutical lines into banner pharmacy.

Recently it was announced that we had signed agreements with TerryWhite Chemmart and API (allowing Medlab to core range its nutraceutical range into the Priceline Pharmacy network). These agreements provide Medlab access to over 2,500 pharmacies.

APP provided a great opportunity for our team to meet with pharmacy banner representatives and to talk everything clinical, science and patents which results in a truly unique offering.

Medlab’s exhibition stand, and in-conference presentations centred around Australian research and the unique business opportunity for the pharmacist.

CEO Communique

For me not only was the APP conference an opportunity to learn current market needs and obstacles and more-so championing “why Medlab” and how it is of benefit to pharmacy customers, I was able to reconnect with old friends and in some cases, staff from my old company, BioCeuticals..

CEO Communique

In short, we were well received and as of right now are onboarding product to the pharmacy distribution centres.

Medlab’s marketing team are working frantically finalising education, media and in-store assets to support the sale of our nutraceutical products.

Our in-field sales people are working diligently with pharmacists to ensure both a smooth entry and educated staff.

Very soon, our placement in pharmacy should be obvious – note, Medlab is not your normal over the counter product, look for it with other “Pharmacy Advice” Medicines

CEO Communique

Dr Sean Hall

Published 4TH March 2019

Keep up to date via:

Medlab’s Social Media Pages:


Dr Sean Hall’s Social Media Pages:

CEO Communique

CEO Communique